The Relationship Between Pelvic Floor Dysfunction and Quality of Life, Functional Capacity, Gait Parameters, and Static Balance in Children With Defecation Disorders

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-18
SponsorIzmir Bakircay University

About this trial

Defecation disorders are common in children and may adversely affect pelvic floor function, gait, balance, functional capacity, and health-related quality of life. Although pelvic floor dysfunction is considered an important component of defecation disorders, its relationship with gait characteristics, plantar pressure distribution, static balance, functional capacity, and health-related quality of life has not been fully investigated in children.

The aim of this study is to investigate the relationship between pelvic floor function and gait parameters, plantar pressure distribution, static balance, functional capacity, and health-related quality of life in children with defecation disorders. Pelvic floor function will be evaluated using surface electromyography and the Kelly Continence Score. Gait parameters, plantar pressure distribution, static balance, functional capacity, and health-related quality of life will be assessed using validated and standardized assessment methods.

Eligibility criteria

Qualifiers

Being between 6 and 18 years of age

Diagnosed with a defecation disorder by a pediatric surgeon according to Rome IV clinical criteria

Having a history of constipation or fecal incontinence lasting at least 3 months

Cognitive and auditory abilities sufficient to understand and follow simple verbal commands

Disqualifiers

Having orthopedic or neurological conditions that would impair lower extremity movements or walking

History of surgery within the last 6 months

History of neurological disorders (e.g., cerebral palsy, epilepsy, neuromuscular diseases)

Having visual or hearing impairments severe enough to prevent participation in the study

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

95 Participants
are grouped into 1 trial group

Sponsors and collaborators

Izmir Bakircay University

Lead sponsor

Ege University

Collaborator